Rixathon®

Random entry RSS

Posted in:
News

Sandoz’s Rixathon® (rituximab) Approved in Europe
By Andrew Storaska June 29, 2017 Comments are off
On June 19, 2017, the European Commission (EC) approved Sandoz’s Rixathon® (rituximab), a biosimilar to Roche/Genentech’s...

Read more

Tagged with: EMA, FDA, Genentech, Mabthera, News, Regulatory, Rituxan®, Rituximab, Rixathon®, Sandoz

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top